|
US4107288A
(en)
|
1974-09-18 |
1978-08-15 |
Pharmaceutical Society Of Victoria |
Injectable compositions, nanoparticles useful therein, and process of manufacturing same
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
US5455242A
(en)
|
1991-09-27 |
1995-10-03 |
Merrell Dow Pharmaceuticals Inc. |
Carboxyalkyl tricyclic derivatives useful as inhibitors of enkephalinase and ace
|
|
US5457196A
(en)
|
1991-09-27 |
1995-10-10 |
Merrell Dow Pharmaceuticals Inc. |
2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
|
|
PT669936E
(pt)
|
1992-10-30 |
2001-04-30 |
Merrell Pharma Inc |
Derivados de lactama biciclica de mercaptoacetilamida uteis como inibidores de encefalinase e de ace
|
|
US5508272A
(en)
|
1993-06-15 |
1996-04-16 |
Bristol-Myers Squibb Company |
Compounds containing a fused bicycle ring and processes therefor
|
|
FR2803594B1
(fr)
|
2000-01-11 |
2002-07-19 |
Centre Nat Rech Scient |
Oligomeres de mimes contraints non peptidiques de dipeptides ou de tripeptides, et leurs utilisations
|
|
WO2004007529A2
(en)
|
2002-07-15 |
2004-01-22 |
The Trustees Of Princeton University |
Iap binding compounds
|
|
BRPI0506883A
(pt)
|
2004-01-16 |
2007-05-29 |
Univ Michigan |
miméticos de smac conformacionalmente comprimidos e seus usos
|
|
EP1723122B1
(en)
|
2004-03-01 |
2014-11-19 |
Board of Regents, The University of Texas System |
Dimeric small molecule potentiators of apoptosis
|
|
US7345081B2
(en)
|
2004-03-23 |
2008-03-18 |
Genentech, Inc. |
Azabicyclo-octane inhibitors of IAP
|
|
PL2253614T3
(pl)
|
2004-04-07 |
2013-03-29 |
Novartis Ag |
Inhibitory IAP
|
|
KR100926203B1
(ko)
|
2004-07-02 |
2009-11-09 |
제넨테크, 인크. |
Ｉａｐ의 억제제
|
|
WO2006010118A2
(en)
|
2004-07-09 |
2006-01-26 |
The Regents Of The University Of Michigan |
Conformationally constrained smac mimetics and the uses thereof
|
|
BRPI0513310A
(pt)
|
2004-07-12 |
2008-05-06 |
Idun Pharmaceuticals Inc |
análogos de tetrapeptìdeo
|
|
JP5230865B2
(ja)
|
2004-07-15 |
2013-07-10 |
テトラロジック ファーマシューティカルズ コーポレーション |
Ｉａｐ結合性化合物
|
|
MX2007007195A
(es)
|
2004-12-20 |
2007-10-08 |
Genentech Inc |
Inhibidores de pirrolidina de iap.
|
|
EA012810B1
(ru)
|
2005-02-25 |
2009-12-30 |
Тетралоджик Фармасеутикалс |
Димерные ингибиторы ингибиторов белков апоптоза (iap)
|
|
AU2006255084A1
(en)
|
2005-06-08 |
2006-12-14 |
Novartis Ag |
Organic compounds
|
|
WO2007041775A1
(en)
|
2005-10-10 |
2007-04-19 |
The University Of Queensland |
Cysteine protease inhibitors incorporating azide groups
|
|
AU2006308453B9
(en)
|
2005-10-25 |
2011-12-01 |
Pharmascience Inc. |
IAP BIR domain binding compounds
|
|
WO2007101347A1
(en)
|
2006-03-07 |
2007-09-13 |
Aegera Therapeutics Inc. |
Bir domain binding compounds
|
|
WO2007107008A1
(en)
|
2006-03-22 |
2007-09-27 |
Innodia Inc. |
Compounds and compositions for use in the prevention and treatment of disorders of fat metabolism and obesity
|
|
ES2525585T3
(es)
|
2006-05-05 |
2014-12-26 |
The Regents Of The University Of Michigan |
Intermedios para la preparación de miméticos de SMAC bivalentes
|
|
US8202902B2
(en)
*
|
2006-05-05 |
2012-06-19 |
The Regents Of The University Of Michigan |
Bivalent SMAC mimetics and the uses thereof
|
|
CA2670726A1
(en)
|
2006-12-07 |
2008-06-19 |
Novartis Ag |
6-oxo-1, 6-dihydropyrimidin-2-yls in the treatment of proliferative diseases
|
|
US20090010941A1
(en)
|
2007-04-09 |
2009-01-08 |
University Of Massachusetts |
Methods for treating HIV
|
|
CA2684169C
(en)
|
2007-04-12 |
2012-06-19 |
Joyant Pharmaceuticals, Inc. |
Smac mimetic dimers and trimers useful as anti-cancer agents
|
|
WO2008128171A2
(en)
|
2007-04-13 |
2008-10-23 |
The Regents Of The University Of Michigan |
Diazo bicyclic smac mimetics and the uses thereof
|
|
NZ598890A
(en)
|
2007-04-30 |
2013-10-25 |
Genentech Inc |
Inhibitors of iap
|
|
CA2591126A1
(en)
|
2007-06-08 |
2008-12-08 |
Kanata Chemical Technologies Inc. |
Process for the preparation of aminiphosphine ligands and their use in metal catalysts
|
|
EP2058312A1
(en)
|
2007-11-09 |
2009-05-13 |
Universita' degli Studi di Milano |
SMAC mimetic compounds as apoptosis inducers
|
|
US8445473B2
(en)
|
2008-04-11 |
2013-05-21 |
The Regents Of The University Of Michigan |
Heteroaryl-substituted bicyclic Smac mimetics and the uses thereof
|
|
CN102159557A
(zh)
|
2008-09-22 |
2011-08-17 |
弗·哈夫曼-拉罗切有限公司 |
哌嗪d3和5-ht2a受体调节剂
|
|
US8642544B2
(en)
|
2009-04-01 |
2014-02-04 |
Amylin Pharmaceuticals, Llc |
N-terminus conformationally constrained GLP-1 receptor agonist compounds
|
|
US20100317593A1
(en)
|
2009-06-12 |
2010-12-16 |
Astrazeneca Ab |
2,3-dihydro-1h-indene compounds
|
|
EP2493879B1
(en)
|
2009-10-28 |
2014-05-14 |
Joyant Pharmaceuticals, Inc. |
Dimeric smac mimetics
|
|
US8394858B2
(en)
|
2009-12-03 |
2013-03-12 |
Novartis Ag |
Cyclohexane derivatives and uses thereof
|
|
WO2011082285A1
(en)
|
2009-12-30 |
2011-07-07 |
Avila Therapeutics, Inc. |
Ligand-directed covalent modification of protein
|
|
EP3351249A1
(en)
|
2010-01-27 |
2018-07-25 |
VIIV Healthcare Company |
Antiviral therapy
|
|
US9346852B2
(en)
|
2011-03-14 |
2016-05-24 |
Bristol-Myers Scuibb Company |
Substituted adipic acid amides and uses thereof
|
|
US20150174235A1
(en)
|
2012-06-06 |
2015-06-25 |
Bionor Immuno As |
Vaccine
|
|
AU2013306087B2
(en)
*
|
2012-08-23 |
2017-08-10 |
The Regents Of The University Of Michigan |
Bivalent inhibitors of IAP proteins and therapeutic methods using the same
|
|
CA2896577C
(en)
|
2012-11-30 |
2024-01-23 |
Sanford-Burnham Medical Research Institute |
Inhibitor of apoptosis protein (iap) antagonists
|
|
JP6768522B2
(ja)
|
2014-06-04 |
2020-10-14 |
サンフォード−バーンハム メディカル リサーチ インスティテュート |
Ｈｉｖ治療におけるアポトーシスタンパク質阻害剤（ｉａｐ）のアンタゴニストの使用
|
|
RU2018132559A
(ru)
*
|
2016-02-16 |
2020-03-17 |
Массачусетс Инститьют Оф Текнолоджи |
Связывающие молекулы для max в качестве модуляторов myc и их применения
|
|
US10870663B2
(en)
*
|
2018-11-30 |
2020-12-22 |
Glaxosmithkline Intellectual Property Development Limited |
Compounds useful in HIV therapy
|
|
CN113613724B
(zh)
*
|
2018-11-30 |
2024-11-08 |
葛兰素史克知识产权开发有限公司 |
可用于hiv疗法的化合物
|
|
US12678509B2
(en)
*
|
2019-11-08 |
2026-07-14 |
Sanford Burnham Prebys Medical Discovery Institute |
Inhibitor of apoptosis (IAP) protein antagonists
|
|
EP4143198A4
(en)
|
2020-04-30 |
2024-05-01 |
Sanford Burnham Prebys Medical Discovery Institute |
INHIBITOR OF APOPTOSIS PROTEIN ANTAGONISTS (API)
|
|
US20250129099A1
(en)
|
2021-11-04 |
2025-04-24 |
Sanford Burnham Prebys Medical Discovery Institute |
Inhibitor of apoptosis (iap) protein antagonists
|